Related Experiment Videos
Cause of death in patients with inflammatory bowel disease
1The Department of Veterans Affairs Medical Center, and The University of New Mexico, Albuquerque 87108, USA.
Insights
Deaths in ulcerative colitis (UC) and Crohn's disease (CD) are linked to similar comorbid conditions and complications. Aggressive treatment for inflammatory bowel disease may increase risks of complications leading to mortality.
Area of Science:
- Gastroenterology
- Internal Medicine
- Public Health
Background:
- Ulcerative colitis (UC) and Crohn's disease (CD) are major causes of mortality in inflammatory bowel disease (IBD).
- Understanding comorbid conditions contributing to IBD mortality is crucial for patient management.
- This study analyzes factors contributing to death in patients with UC and CD.
Purpose of the Study:
- To identify and analyze comorbid medical conditions associated with mortality in patients diagnosed with ulcerative colitis and Crohn's disease.
- To determine the common causes of death in patients suffering from these inflammatory bowel diseases.
- To provide data for improved clinical management strategies for IBD.
Main Methods:
- Utilized United States vital statistics data from 1991-1996 from the National Center for Health Statistics.
- Extracted death records for patients with ulcerative colitis and Crohn's disease.
- Calculated proportional mortality ratios for comorbid conditions, adjusted for age, gender, and race.
Main Results:
- UC and CD share a similar profile of comorbid conditions and complications leading to death.
- Frequent comorbidities included nutritional deficiencies (malnutrition, anemia) and fluid/electrolyte imbalances (shock, volume depletion).
- Peritonitis, septicemia, and complications from medical/surgical interventions were significant contributors to mortality.
Conclusions:
- Mortality in inflammatory bowel disease is often linked to complications arising from medical and surgical interventions.
- Physicians must consider the potential for complications associated with aggressive treatment strategies in IBD management.
- Proactive management of comorbidities and treatment-related complications is essential for reducing IBD mortality.
Background:
Ulcerative colitis (UC) and Crohn's disease (CD) can both result in disease-related mortality. The aim of the present study was to analyze the comorbid medical conditions that contribute to death of patients with inflammatory disease.
Methods:
The United States' vital statistics offer the opportunity to study causes of death broken down by primary and contributing secondary conditions. Deaths from UC and CD were retrieved from the 1991-1996 data files of the National Center for Health Statistics. The strengths of individual associations between each comorbid condition and UC or CD were expressed as proportional mortality ratios, adjusted to the age-, gender-, and race-distribution of the general population.
Results:
Deaths from UC and CD were found to be associated with a similar set of comorbid conditions and complications. Shock, volume depletion, protein/calorie malnutrition, and anemia were the most frequent comorbid conditions in the group of nutritional, fluid, and electrolyte disturbances. Both diseases were frequently associated with peritonitis and septicemia. Lastly, a large number of deaths were associated with complications following medical and surgical interventions.
Conclusions:
Deaths due to inflammatory bowel disease appear to be related to complications from multiple medical interventions and surgical procedures. In managing inflammatory bowel disease, the physician must keep in mind the potential for complications that may be associated with aggressive treatment.